U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT07470658) titled 'Optimal Surveillance Strategy After Positive FIT and Negative Colonoscopy' on March 10.
Brief Summary: Individuals with high fecal hemoglobin concentrations detected by fecal immunochemical testing (FIT) but negative findings on high-quality colonoscopy represent a clinically challenging population. Although colonoscopy is considered the gold standard diagnostic procedure, previous studies suggest that these individuals may still have an elevated long-term risk of colorectal cancer.
This randomized controlled trial aims to determine the optimal surveillance strategy for this high-risk group by comparing two approaches: repeat FIT ...